Board Meetings for QMSMEDI

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
QMSMEDIQMS Medical Allied Services Limited30 May 2026Financial Results/Dividend/Other business mattersTo consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
QMSMEDIQMS Medical Allied Services Limited30 May 2026Board Meeting IntimationQMS MEDICAL ALLIED SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend.
QMSMEDIQMS Medical Allied Services Limited14 Feb 2026Board Meeting IntimationQMS MEDICAL ALLIED SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 14-Feb-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 .
QMSMEDIQMS Medical Allied Services Limited14 Feb 2026Other business matters1. To consider and approve the Standalone Unaudited Financial Results of the Company along with Limited Review Report for the Quarter ended December 31, 2025.2. To consider and approve the Consolidated Unaudited Financial Results of the Company along with Limited Review Report for the Quarter ended December 31, 2025.
QMSMEDIQMS Medical Allied Services Limited13 Nov 2025Financial ResultsTo consider and approve the financial results for the period ended September 30, 2025
QMSMEDIQMS Medical Allied Services Limited13 Nov 2025Board Meeting IntimationQMS MEDICAL ALLIED SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2025 .
QMSMEDIQMS Medical Allied Services Limited29 Aug 2025Board Meeting IntimationQMS MEDICAL ALLIED SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 29-Aug-2025 to consider Fund raising.
QMSMEDIQMS Medical Allied Services Limited29 Aug 2025Fund RaisingIn compliance with Regulation 29(1)(d) and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"), we hereby inform you that a meeting of the Board of Directors of QMS Medical Allied Services Limited ("the Company") is scheduled to be held on Friday, August 29, 2025, to inter-alia, consider and decide on various matters in connection with aforesaid Rights Issue such as determination of Issue price, Rights Entitlement ratio, Record Date and other terms and conditions with respect to the Rights Issue, subject to the receipt of in-principle approval from the stock exchanges where the securities of the Company are listed or such other regulatory authorities as may be required.
QMSMEDIQMS Medical Allied Services Limited22 Aug 2025Fund RaisingTo consider Fund Raising
QMSMEDIQMS Medical Allied Services Limited22 Aug 2025Board Meeting IntimationQMS MEDICAL ALLIED SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 22-Aug-2025 to consider Fund raising.
QMSMEDIQMS Medical Allied Services Limited13 Aug 2025Board Meeting IntimationQMS MEDICAL ALLIED SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 13-Aug-2025 to consider Other business.
QMSMEDIQMS Medical Allied Services Limited13 Aug 2025Other business mattersTo consider other business matters
QMSMEDIQMS Medical Allied Services Limited29 May 2025Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2025 and dividend
QMSMEDIQMS Medical Allied Services Limited29 May 2025Board Meeting IntimationQMS MEDICAL ALLIED SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2025 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2025 and Dividend.
QMSMEDIQMS Medical Allied Services Limited14 Feb 2025Other business matters1. To consider and approve the Standalone Unaudited Financial Results of the Company along with Limited Review Report for the Quarter year ended December 31, 2024.2. To consider and approve the Consolidated Unaudited Financial Results of the Company along with Limited Review Report for the Quarter ended December 31, 2024
Showing page 1 of 3 (33 total items)
Next